Trials / Completed
CompletedNCT01277341
Safety and Efficacy of Bepotastine Besilate Nasal Spray in the Treatment of Seasonal Allergic Rhinitis
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 601 (actual)
- Sponsor
- Bausch & Lomb Incorporated · Industry
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
This is an efficacy study of bepotastine besilate nasal spray in seasonal allergic rhinitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Bepotastine Besilate Nasal Spray 2% Twice a day | nasal spray |
| DRUG | Bepotastine Besilate Nasal Spray 3% Twice a day | nasal spray |
| DRUG | Bepotastine Besilate Nasal Spray 4% Twice a day | nasal spray |
| DRUG | Placebo Nasal Spray | nasal spray |
Timeline
- Start date
- 2010-12-01
- Primary completion
- 2011-02-01
- Completion
- 2011-05-01
- First posted
- 2011-01-14
- Last updated
- 2020-10-05
- Results posted
- 2020-09-14
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01277341. Inclusion in this directory is not an endorsement.